These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 35741435)
21. The Gaucher earlier diagnosis consensus point-scoring system (GED-C PSS): Evaluation of a prototype in Finnish Gaucher disease patients and feasibility of screening retrospective electronic health record data for the recognition of potential undiagnosed patients in Finland. Savolainen MJ; Karlsson A; Rohkimainen S; Toppila I; Lassenius MI; Falconi CV; Uusi-Rauva K; Elomaa K Mol Genet Metab Rep; 2021 Jun; 27():100725. PubMed ID: 33604241 [TBL] [Abstract][Full Text] [Related]
22. Glucocerebrosidase and its relevance to Parkinson disease. Do J; McKinney C; Sharma P; Sidransky E Mol Neurodegener; 2019 Aug; 14(1):36. PubMed ID: 31464647 [TBL] [Abstract][Full Text] [Related]
23. The role of neurogenetics in Gaucher disease. Brady RO; Barton NW; Grabowski GA Arch Neurol; 1993 Nov; 50(11):1212-24. PubMed ID: 8215980 [TBL] [Abstract][Full Text] [Related]
25. Clinical manifestations and management of Gaucher disease. Linari S; Castaman G Clin Cases Miner Bone Metab; 2015; 12(2):157-64. PubMed ID: 26604942 [TBL] [Abstract][Full Text] [Related]
26. Two novel mutations in glucocerebrosidase, C23W and IVS7-1 G>A, identified in Type 1 Gaucher patients heterozygous for N370S. Jack A; Amato D; Morris G; Choy FY Gene; 2014 Mar; 538(1):84-7. PubMed ID: 24434810 [TBL] [Abstract][Full Text] [Related]
27. A Drosophila Model of Neuronopathic Gaucher Disease Demonstrates Lysosomal-Autophagic Defects and Altered mTOR Signalling and Is Functionally Rescued by Rapamycin. Kinghorn KJ; Grönke S; Castillo-Quan JI; Woodling NS; Li L; Sirka E; Gegg M; Mills K; Hardy J; Bjedov I; Partridge L J Neurosci; 2016 Nov; 36(46):11654-11670. PubMed ID: 27852774 [TBL] [Abstract][Full Text] [Related]
28. Progress and potential of non-inhibitory small molecule chaperones for the treatment of Gaucher disease and its implications for Parkinson disease. Jung O; Patnaik S; Marugan J; Sidransky E; Westbroek W Expert Rev Proteomics; 2016 May; 13(5):471-9. PubMed ID: 27098312 [TBL] [Abstract][Full Text] [Related]
29. Liver involvement in Gaucher disease: A practical review for the hepatologist and the gastroenterologist. Carubbi F; Cappellini MD; Fargion S; Fracanzani AL; Nascimbeni F Dig Liver Dis; 2020 Apr; 52(4):368-373. PubMed ID: 32057684 [TBL] [Abstract][Full Text] [Related]
30. Gaucher Disease and Myelofibrosis: A Combined Disease or a Misdiagnosis? Mariani S; Palumbo G; Cardarelli L; Santopietro M; Foà R; Giona F Acta Haematol; 2018; 139(4):240-242. PubMed ID: 29945135 [TBL] [Abstract][Full Text] [Related]
31. Clinical utility of different bone marrow examination methods in the diagnosis of adults with sporadic Gaucher disease type 1. Machaczka M; Markuszewska-Kuczyńska A; Regenthal S; Jurczyszyn A; Gałązka K; Wahlin BE; Klimkowska M Pol Arch Med Wewn; 2014; 124(11):587-92. PubMed ID: 25188399 [TBL] [Abstract][Full Text] [Related]
32. Hyperferritinemia, iron overload, and multiple metabolic alterations identify patients at risk for nonalcoholic steatohepatitis. Fargion S; Mattioli M; Fracanzani AL; Sampietro M; Tavazzi D; Fociani P; Taioli E; Valenti L; Fiorelli G Am J Gastroenterol; 2001 Aug; 96(8):2448-55. PubMed ID: 11513189 [TBL] [Abstract][Full Text] [Related]